Back to Search
HEATH SHOWALTER, MD
MD
Internal Medicine Physician
NPI: 1649494808IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
E-5349(AR)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 2004
Research & Publications (14)
A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
PMID 18762151·Tuberculosis (Edinb)·2008
6-review
Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds.
PMID 19497294·Anal Biochem·2009
7-preclinical
Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones.
PMID 18752951·Bioorg Med Chem Lett·2008
8-other
Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors.
PMID 17196390·Bioorg Med Chem Lett·2007
8-other
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
PMID 17064062·J Med Chem·2006
8-other
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors.
PMID 16480284·J Med Chem·2006
7-preclinical
Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.
PMID 16000000·J Med Chem·2005
7-preclinical
Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents.
PMID 15357962·Bioorg Med Chem Lett·2004
8-other
Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor.
PMID 11462982·J Med Chem·2001
7-preclinical
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity.
PMID 11384237·J Med Chem·2001
7-preclinical
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.
PMID 11063616·J Med Chem·2000
7-preclinical
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
PMID 10974196·Biochem Pharmacol·2000
8-other
Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src).
PMID 10956222·J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10001 LILE DR
LITTLE ROCK, AR 72205 - Phone
- (501) 227-8000
Quick Facts
- NPI
- 1649494808
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 14
Are you this provider?
Claim Your Profile